|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 384.70 INR | +0.01% |
|
-0.74% | +24.00% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 363M 319M 296M 272M 511M 520M 3.54B 1.38B 17.12B 1.36B 1.33B 59.4B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 390M 343M 319M 293M 550M 560M 3.81B 1.49B 18.44B 1.47B 1.43B 63.96B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
23.47% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | +0.06% | ||
| 1 week | -0.74% | ||
| Current month | -6.70% | ||
| 1 month | +1.69% | ||
| 3 months | -2.97% | ||
| 6 months | +28.54% | ||
| Current year | +24.00% |
| 1 week | 378 |  | 393.35 |
| 1 month | 374 | | 438.3 |
| Current year | 293.15 | | 447.8 |
| 1 year | 207.99 | | 447.8 |
| 3 years | 111.3 | | 447.8 |
| 5 years | 54.55 | | 447.8 |
| 10 years | 24 | | 447.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 30/08/1990 | |
| Director of Finance/CFO | - | 13/09/2017 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 30/08/1990 | |
| Director/Board Member | 75 | 12/08/2024 | |
| Director/Board Member | 64 | 12/08/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | -0.74% | +61.21% | +246.29% | 372M | |
| -0.60% | +0.49% | +14.78% | +76.48% | 48.41B | |
| +2.20% | +1.41% | +61.04% | +111.43% | 34.99B | |
| +1.37% | -0.51% | -5.13% | +34.56% | 11.62B | |
| -0.54% | -3.14% | +14.06% | +80.48% | 11.47B | |
| -1.68% | -0.19% | +36.83% | +136.73% | 8.99B | |
| +1.52% | +0.39% | +48.79% | -5.82% | 6.88B | |
| +0.26% | -2.50% | +13.62% | +31.02% | 6.62B | |
| -0.68% | -2.04% | +2.14% | +177.81% | 6.43B | |
| +1.60% | -15.49% | -29.66% | +8.47% | 5.75B | |
| Average | +0.35% | -1.75% | +21.77% | +89.74% | 14.15B | |
| Weighted average by Cap. | +0.41% | -1.08% | +25.26% | +81.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 73.24M 64.41M 59.84M 55.04M 103M 105M 716M 279M 3.46B 275M 269M 12B | 7.83B 80.83M 71.09M 66.04M 60.74M 114M 116M 790M 308M 3.82B 303M 297M 13.25B |
| Net income | 498M 5.15M 4.53M 4.2M 3.87M 7.25M 7.38M 50.27M 19.61M 243M 19.32M 18.9M 843M | 691M 7.14M 6.28M 5.83M 5.36M 10.06M 10.24M 69.75M 27.21M 337M 26.8M 26.22M 1.17B |
| Net Debt | 2.45B 25.26M 22.22M 20.64M 18.98M 35.6M 36.24M 247M 96.28M 1.19B 94.84M 92.79M 4.14B | 2.69B 27.8M 24.45M 22.72M 20.89M 39.18M 39.89M 272M 106M 1.31B 104M 102M 4.56B |
Employees
1,470
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ₹384.70 | +0.01% | 28,167 |
| 23/07/26 | ₹384.65 | -0.49% | 160,315 |
| 22/07/26 | ₹386.55 | -0.43% | 139,978 |
| 21/07/26 | ₹388.20 | +0.98% | 64,631 |
| 20/07/26 | ₹384.45 | -0.85% | 60,828 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
